@article{f534ac2ce2eb474b97764fc2abd84709,
title = "Glecaprevir/Pibrentasvir (Mavyret) for the Treatment of Chronic Hepatitis C.",
author = "Anupriya Grover and Erlich, \{Deborah R.\}",
note = "Glecaprevir/pibrentasvir is an effective treatment for any of six genotypes of HCV infection and has few adverse effects. It can be used to treat more genotypes over a shorter duration (eight weeks for patients without cirrhosis) and is substantially less expensive than other available treatments.",
year = "2018",
month = nov,
day = "15",
language = "American English",
volume = "98",
journal = "American Family Physician",
issn = "1532-0650",
publisher = "American Academy of General Practice",
number = "10",
}